Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;38(7):e25032.
doi: 10.1002/jcla.25032. Epub 2024 Mar 25.

A Systematic Literature Review on the Use of Dried Biofluid Microsampling in Patients With Kidney Disease

Affiliations

A Systematic Literature Review on the Use of Dried Biofluid Microsampling in Patients With Kidney Disease

Megan K Lamond et al. J Clin Lab Anal. 2024 Apr.

Abstract

Background: Kidney disease is fairly unique due to the lack of symptoms associated with disease activity, and it is therefore dependent on biological monitoring. Dried biofluids, particularly dried capillary blood spots, are an accessible, easy-to-use technology that have seen increased utility in basic science research over the past decade. However, their use is yet to reach the kidney patient population clinically or in large-scale discovery science initiatives. The aim of this study was to systematically evaluate the existing literature surrounding the use of dried biofluids in kidney research.

Methods: A systematic literature review was conducted using three search engines and a predefined search term strategy. Results were summarised according to the collection method, type of biofluid, application to kidney disease, cost, sample stability and patient acceptability.

Results: In total, 404 studies were identified and 67 were eligible. In total, 34,739 patients were recruited to these studies with a skew towards male participants (> 73%). The majority of samples were blood, which was used either for monitoring anti-rejection immunosuppressive drug concentrations or for kidney function. Dried biofluids offered significant cost savings to the patient and healthcare service. The majority of patients preferred home microsampling when compared to conventional monitoring.

Conclusion: There is an unmet need in bringing dried microsampling technology to advance kidney disease despite its advantages. This technology provides an opportunity to upscale patient recruitment and longitudinal sampling, enhance vein preservation and overcome participation bias in research.

Keywords: dried blood spot (DBS); dried saliva spot; dried urine spot (DUS); microsampling; renal.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
PRISMA diagram showing the inclusion and exclusion of studies of dried biofluids in kidney research.
FIGURE 2
FIGURE 2
Schematic of the duration of analyte stability when using volumetric absorptive microsampling (VAMS) devices (top row) or dried blood spot (DBS) on filter paper (bottom row) according to storage temperature. Created with BioRender.com.

References

    1. Chadban S. and Atkins R., “Glomerulonephritis,” The Lancet 365, no. 9473 (2005): 1797–1806. - PubMed
    1. Silver M. R., “Saving Veins, Saving Lives, for Patients With Chronic Kidney Disease,” Annals of Internal Medicine 171, no. 1 (2019): 60–61. - PubMed
    1. Singh N. S., Grimes J., Gregg G. K., et al., “‘Save the Vein’ Initiative in Children With CKD: A Quality Improvement Study,” American Journal of Kidney Diseases 78, no. 1 (2021): 96–102.e1. - PubMed
    1. Zoccali C., Vanholder R., Wagner C. A., et al., “Funding Kidney Research as a Public Health Priority: Challenges and Opportunities,” Nephrology, Dialysis, Transplantation 37, no. 1 (2021): 21–28. - PubMed
    1. Nugent R. A., Fathima S. F., Feigl A. B., and Chyung D., “The Burden of Chronic Kidney Disease on Developing Nations: A 21st Century Challenge in Global Health,” Nephron Clinical Practice 118, no. 3 (2011): c269–c277. - PubMed

Publication types